Reduction of CEACAM1 levels in cultured tumor cells and in endogenous tumors from WAP-T/CEACAM1null mice was associated with decreased phosphorylation of β-catenin on S33/37/T41, a hallmark of activated Wnt/β-catenin pathway [51]. The gene discussed is CEACAM1; the disease is neoplasm.